Replies to post #141205 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Actually the jury is out on that. There is speculation that the weak short lived benefit of Donepezil may be down to its S1 agonism.

https://www.sciencedirect.com/science/article/pii/S1347861314000176

https://www.ncbi.nlm.nih.gov/pubmed/22288409

https://www.ncbi.nlm.nih.gov/pubmed/28315270